Overview

A Study Comparing High Dose Omeprazole Infusion Against Scheduled Second Endoscopy for Bleeding Peptic Ulcer

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
A prospective randomized study to compare the adjunctive use of high dose omeprazole infusion against scheduled second endoscopy in prevention of peptic ulcer rebleeding after therapeutic endoscopy.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Chinese University of Hong Kong
Treatments:
Omeprazole
Criteria
Inclusion Criteria:

- all consecutive patients admitted for peptic ulcer bleeding (including bleeding
anastomotic ulcers) with emergency endoscopy done in 24 hours after admission with
Forrest type Ia, Ib, and IIa, IIb

- age 15 - 90 years

- Written consent available

Exclusion Criteria:

- ulcer bleeding not controlled in first endoscopy

- Bleeding from malignant ulcer or tumor

- Bleeding from Dieulafoy lesion/ angiodysplasia

- Bleeding from injection sclerotherapy ulcer

- Patient with ASA category 5